Minnie Baylor Henry is Director of Paratek Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of PRTK, which is worth approximately $0. The most recent transaction as insider was on Sep 21, 2023, when has been sold 59,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Minnie Baylor-Henry Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 21 2023
SELL
Sale (or disposition) back to the issuer
-
59,200 Reduced 100.0%
0 Common Stock
Feb 08 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 25.25%
59,200 Common Stock
Feb 16 2022
BUY
Grant, award, or other acquisition
-
20,000 Added 33.78%
39,200 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
-
19,200 Added 50.0%
19,200 Common Stock

Also insider at

PTE
POLARITYTE, INC. Healthcare
SCPH
scPharmaceuticals Inc. Healthcare
APYX
Apyx Medical Corp Healthcare
LNTH
Lantheus Holdings, Inc. Healthcare
MB

Minnie Baylor Henry

Director
Clearwater, FL

Track Institutional and Insider Activities on PRTK

Follow Paratek Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRTK shares.

Notify only if

Insider Trading

Get notified when an Paratek Pharmaceuticals, Inc. insider buys or sells PRTK shares.

Notify only if

News

Receive news related to Paratek Pharmaceuticals, Inc.

Track Activities on PRTK